Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits
- 15 July 2014
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 161 (2) , 104-112
Abstract
The net benefit of cancer screening depends on the patient's age and comorbid conditions, but reliable methods of evaluating when to cease screening are lacking. This modeling study estimated the h... Background: Harms and benefits of cancer screening depend on age and comorbid conditions, but reliable estimates are lacking. Objective: To estimate the harms and benefits of cancer screening by ag...Keywords
This publication has 50 references indexed in Scilit:
- Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening StrategiesAnnals of Internal Medicine, 2013
- Toward optimal screening strategies for older womenJournal of General Internal Medicine, 2005
- Diet, lifestyle and risk of prostate cancerActa Oncologica, 2005
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI: Journal of the National Cancer Institute, 2003
- Cancer Screening in Elderly PatientsJAMA, 2001
- Development of a comorbidity index using physician claims dataJournal of Clinical Epidemiology, 2000
- Cost-effectiveness of Screening for Colorectal Cancer in the General PopulationJAMA, 2000
- When should we stop screening?2000
- The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer ScreeningComputers and Biomedical Research, 1999
- Breast Cancer Screening for Elderly Women with and without Comorbid ConditionsAnnals of Internal Medicine, 1992